Euromedis Groupe (ALEMG.PA)
EUR 4.45
(0.23%)
EUR 4.45
(0.23%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -8.82 Million EUR | 36.79% |
| 2022 | -13.96 Million EUR | 14.5% |
| 2021 | -16.33 Million EUR | -908.47% |
| 2020 | 2.02 Million EUR | -88.91% |
| 2019 | 18.21 Million EUR | 35.88% |
| 2018 | 13.4 Million EUR | 54.83% |
| 2017 | 8.65 Million EUR | 10.35% |
| 2016 | 7.84 Million EUR | -0.93% |
| 2015 | 7.92 Million EUR | -13.85% |
| 2014 | 9.19 Million EUR | -6.19% |
| 2013 | 9.8 Million EUR | 731.51% |
| 2012 | -1.55 Million EUR | -136.03% |
| 2011 | 4.3 Million EUR | 94.4% |
| 2010 | 2.21 Million EUR | -32.15% |
| 2009 | 3.26 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -9.62 Million EUR | 0.0% |
| 2023 Q4 | -8.82 Million EUR | 0.0% |
| 2023 Q3 | -8.82 Million EUR | 14.9% |
| 2023 Q2 | -10.37 Million EUR | 0.06% |
| 2023 Q1 | -10.37 Million EUR | 25.67% |
| 2023 FY | -8.82 Million EUR | 36.79% |
| 2022 FY | -13.96 Million EUR | 14.5% |
| 2022 Q3 | -13.96 Million EUR | 13.84% |
| 2022 Q2 | -16.2 Million EUR | -0.39% |
| 2022 Q1 | -16.14 Million EUR | 1.16% |
| 2022 Q4 | -13.96 Million EUR | 0.0% |
| 2021 Q1 | -465 Thousand EUR | -123.02% |
| 2021 FY | -16.33 Million EUR | -908.47% |
| 2021 Q3 | -16.32 Million EUR | -3426.78% |
| 2021 Q2 | -463 Thousand EUR | 0.43% |
| 2021 Q4 | -16.33 Million EUR | -0.01% |
| 2020 Q3 | 2.01 Million EUR | 219.1% |
| 2020 Q1 | -1.69 Million EUR | -109.32% |
| 2020 FY | 2.02 Million EUR | -88.91% |
| 2020 Q2 | -1.69 Million EUR | 0.06% |
| 2020 Q4 | 2.02 Million EUR | 0.0% |
| 2019 Q2 | 15.61 Million EUR | 7.14% |
| 2019 Q4 | 18.21 Million EUR | 22.25% |
| 2019 Q3 | 14.9 Million EUR | -4.57% |
| 2019 FY | 18.21 Million EUR | 35.88% |
| 2019 Q1 | 14.57 Million EUR | 0.0% |
| 2018 FY | 13.4 Million EUR | 54.83% |
| 2017 Q1 | 9.95 Million EUR | 9.03% |
| 2017 FY | 8.65 Million EUR | 10.35% |
| 2017 Q4 | 9.52 Million EUR | -6.18% |
| 2017 Q3 | 10.15 Million EUR | 17.28% |
| 2017 Q2 | 8.65 Million EUR | -13.04% |
| 2016 FY | 7.84 Million EUR | -0.93% |
| 2016 Q4 | 9.13 Million EUR | 5.77% |
| 2016 Q1 | 7.31 Million EUR | 0.26% |
| 2016 Q2 | 7.84 Million EUR | 7.33% |
| 2016 Q3 | 8.63 Million EUR | 10.03% |
| 2015 FY | 7.92 Million EUR | -13.85% |
| 2015 Q2 | 7.92 Million EUR | 7.19% |
| 2015 Q1 | 7.39 Million EUR | -34.69% |
| 2015 Q4 | 7.29 Million EUR | 6.94% |
| 2015 Q3 | 6.81 Million EUR | -13.91% |
| 2014 Q4 | 11.31 Million EUR | 4.89% |
| 2014 FY | 9.19 Million EUR | -6.19% |
| 2014 Q2 | 9.19 Million EUR | 11.27% |
| 2014 Q1 | 8.26 Million EUR | -15.1% |
| 2014 Q3 | 10.78 Million EUR | 17.34% |
| 2013 Q2 | 9.8 Million EUR | 0.0% |
| 2013 Q3 | 9.4 Million EUR | -4.0% |
| 2013 Q4 | 9.73 Million EUR | 3.44% |
| 2013 Q1 | 9.8 Million EUR | -16.55% |
| 2013 FY | 9.8 Million EUR | 731.51% |
| 2012 Q1 | -1.55 Million EUR | 3.66% |
| 2012 Q4 | 11.74 Million EUR | 4.25% |
| 2012 Q3 | 11.26 Million EUR | 825.9% |
| 2012 Q2 | -1.55 Million EUR | 0.0% |
| 2012 FY | -1.55 Million EUR | -136.03% |
| 2011 Q3 | -1.61 Million EUR | -137.4% |
| 2011 FY | 4.3 Million EUR | 94.4% |
| 2011 Q4 | -1.61 Million EUR | 0.0% |
| 2011 Q2 | 4.3 Million EUR | 0.0% |
| 2010 Q2 | 2.21 Million EUR | 0.0% |
| 2010 Q4 | 805 Thousand EUR | 0.0% |
| 2010 FY | 2.21 Million EUR | -32.15% |
| 2009 FY | 3.26 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Affluent Medical SA | 15.47 Million EUR | 157.031% |
| Bluelinea Société Anonyme | -870.82 Thousand EUR | -913.536% |
| Carmat SA | 49.63 Million EUR | 117.782% |
| Diagnostic Medical Systems S.A. | 11.52 Million EUR | 176.563% |
| Eurobio Scientific Société anonyme | 51.33 Million EUR | 117.194% |
| Ikonisys S.A. | 3.19 Million EUR | 375.981% |
| Implanet S.A. | 5.9 Million EUR | 249.52% |
| Median Technologies SA | 3.5 Million EUR | 351.744% |
| SpineGuard SA | 215.79 Thousand EUR | 4190.023% |
| Theraclion SA | -5.86 Million EUR | -50.5% |
| Euroapi S.A. | 191 Million EUR | 104.621% |
| Guerbet SA | 332.59 Million EUR | 102.654% |
| Ion Beam Applications SA | -67.72 Million EUR | 86.967% |
| Koninklijke Philips N.V. | 5.82 Billion EUR | 100.152% |
| Sequana Medical NV | 14.2 Million EUR | 162.144% |